Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

Delayed Data
As of Oct 21
 -0.16 / -2.43%
Today’s Change
Today|||52-Week Range
Array BioPharma (ARRY) is in Overbought Territory: What's Next?
Oct 14 / Zacks.com - Paid Partner Content
3 Cancer Drugs That Could Get an FDA OK Next Year
Oct 09 / MotleyFool.com - Paid Partner Content
Why Array BioPharma Skyrocketed 91% in September
Oct 10 / MotleyFool.com - Paid Partner Content